Pharmacy
The company recently partnered with UW Medicine and Alaska Airlines to move specialty medications from Seattle to Spokane, shortening the route, reducing time and packaging for home deliveries, says CEO Amit Gir.
The new estimate is $3.7 billion higher than the agency's previous projections, CBO says.
Manufacturer EMD Serono is engaged by the Trump administration to bring the price of the medicine down by 84%.
Nationwide, there are inconsistencies in beneficiaries’ ability to afford care, access doctors, meet prior authorization requirements and avoid unnecessary hospitalizations.
The bill requires PBMs to be licensed and end the practice of spread pricing, among other requirements.
The drugmaker will sell medications to Medicaid at most favored nation prices, the administration says.
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
FDA will begin notifying physicians that pregnant women should avoid taking Tylenol during pregnancy unless absolutely necessary.